MONOPHARMA2026-09-04MONOPHARMA2026-09-042026-09-04RelatedPartyTransactionDomain1MONOPHARMA2026-09-042026-09-04RelatedPartyTransactionDomain2MONOPHARMA2026-09-042026-09-04RelatedPartyTransactionDomain3MONOPHARMA2026-09-042026-09-04RelatedPartyTransactionDomain4MONOPHARMA2026-09-042026-09-04RelatedPartyTransactionDomain5MONOPHARMA2026-09-042026-09-04RelatedPartyTransactionDomain6MONOPHARMA2026-09-042026-09-04RelatedPartyTransactionDomain7MONOPHARMA2026-09-042026-09-04ResolutionOrAgendaDomain1MONOPHARMA2026-09-04ResolutionOrAgendaDomain1MONOPHARMA2026-09-042026-09-04ResolutionOrAgendaDomain2MONOPHARMA2026-09-04ResolutionOrAgendaDomain2MONOPHARMA2026-09-042026-09-04ResolutionOrAgendaDomain3MONOPHARMA2026-09-04ResolutionOrAgendaDomain3MONOPHARMA2026-09-042026-09-04ResolutionOrAgendaDomain4MONOPHARMA2026-09-04ResolutionOrAgendaDomain4iso4217:INRxbrli:pureMONOPHARMAMONO PHARMACARE LIMITEDNew2026-09-0316:00:002026-09-04Annual General MeetingPhysical Meeting1WEDNESDAY2026-09-3011:00:00AHMEDABAD4MONO PHARMACARE LIMITEDSupal PharmaManaging Director of the Company is a partnerAny other transactionSale/ Purchase1400000002026-04-012027-03-31MONO PHARMACARE LIMITEDSupal Pharmacare LtdCommon DirectorsAny other transactionSale/ Purchase1600000002027-04-012028-03-31MONO PHARMACARE LIMITEDSupal Medical & Wholesale LLPDirectors of the Company are partnersAny other transactionSale/ Purchase400000002028-04-012029-03-31MONO PHARMACARE LIMITEDSupal Trading LLCDirectors of the Company are partnersAny other transactionSale/ Purchase1100000002029-04-012030-03-31MONO PHARMACARE LIMITEDPanilam Lakhtariya HUFKarta is the Managing Director of the CompanyAny other transactionSale/ Purchase1200000002030-04-012031-03-31MONO PHARMACARE LIMITEDSupal Distributors LLPSubsidiary EntityAny other transactionSale/ Purchase1200000002031-04-012032-03-31MONO PHARMACARE LIMITEDAhmedabad Medical CorporationSubsidiary EntityAny other transactionSale/ Purchase1100000002032-04-012033-03-31Ordinary ResolutionAdoption of Financial StatementsTo receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended 31st March, 2026 and the Reports of the Board of Directors and Auditors thereon.Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRetirement by rotationTo appoint a Director in place of Mr. PANILAM LAKHATARIYA (DIN: 07659275), who retires by rotation and being eligible, offers himself for re-appointment.Executive DirectorMr. PANILAM LAKHATARIYA076592752023-03-222028-03-21Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationAppointmentTo appoint the M/s R K Mergu & Co. Chartered Accountants, (FRN: 136876W) as a Statutory Auditor of the company.OthersSTATUTORY AUDITORM/s. R K Mergu & Co., Chartered Accountants (Firm Registration No. 136876W)2026-04-012031-03-31Ordinary ResolutionRelated Party TransactionApproval of related party transactions to be entered into for F.Y. 2026-27